" >
“Statin therapy appears to increase the risk for type 2 diabetes by 46%, even after adjustment for confounding factors, a large new population-based study concludes.”
That’s according to Medscape, who reported on the Finnish study.
That means that there is a higher risk for diabetes with statins than was thought before, the researchers suggest.
The diabetes risk associated with statins was correlated with the amount of the dose taken (most of the study participants were taking simvastatin or atorvastatin).
“Therefore I wouldn’t make a conclusion from my study that people should stop statin treatment, especially those patients who have a history of myocardial infarction or so on.
“But what I would say is that people who are at the higher risk, if they are obese, if they have diabetes in the family, etc, should try to lower their statin dose, if possible, because high-dose statin treatment increases the risk vs lower-dose statin treatment,” said researcher Alvin C Powers, MD.
The study used nondiabetic men age 45 to 73 with a six year follow up.
